Frey KA - Search Results

1

Effect of hyperglycemia on brain and liver ¹⁸F-FDG standardized uptake value (FDG SUV) measured by quantitative positron emission tomography (PET) imaging.

Viglianti BL, Wong KK, Wimer SM, Parameswaran A, Nan B, Ky C, Townsend DM, Rubello D, Frey KA, Gross MD. Viglianti BL, et al. Among authors: frey ka. Biomed Pharmacother. 2017 Apr;88:1038-1045. doi: 10.1016/j.biopha.2017.01.166. Epub 2017 Feb 7. Biomed Pharmacother. 2017. PMID: 28192877 Free PMC article.

2

In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography.

Frey KA, Koeppe RA, Mulholland GK, Jewett D, Hichwa R, Ehrenkaufer RL, Carey JE, Wieland DM, Kuhl DE, Agranoff BW. Frey KA, et al. J Cereb Blood Flow Metab. 1992 Jan;12(1):147-54. doi: 10.1038/jcbfm.1992.18. J Cereb Blood Flow Metab. 1992. PMID: 1727135

3

Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.

Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Meyer M, et al. Among authors: frey ka. Arch Neurol. 1995 Mar;52(3):314-7. doi: 10.1001/archneur.1995.00540270110027. Arch Neurol. 1995. PMID: 7872887

4

Positron emission tomography measures of benzodiazepine receptors in Huntington's disease.

Holthoff VA, Koeppe RA, Frey KA, Penney JB, Markel DS, Kuhl DE, Young AB. Holthoff VA, et al. Among authors: frey ka. Ann Neurol. 1993 Jul;34(1):76-81. doi: 10.1002/ana.410340114. Ann Neurol. 1993. PMID: 8390806 Free article.

5

Discordance between F-18 fluorodeoxyglucose uptake and contrast enhancement in a brain abscess.

Meyer MA, Frey KA, Schwaiger M. Meyer MA, et al. Among authors: frey ka. Clin Nucl Med. 1993 Aug;18(8):682-4. doi: 10.1097/00003072-199308000-00013. Clin Nucl Med. 1993. PMID: 8403702

6

In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.

Kilbourn MR, DaSilva JN, Frey KA, Koeppe RA, Kuhl DE. Kilbourn MR, et al. Among authors: frey ka. J Neurochem. 1993 Jun;60(6):2315-8. doi: 10.1111/j.1471-4159.1993.tb03521.x. J Neurochem. 1993. PMID: 8492135 Free article.

7

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

Albin RL, Minoshima S, D'Amato CJ, Frey KA, Kuhl DA, Sima AA. Albin RL, et al. Among authors: frey ka. Neurology. 1996 Aug;47(2):462-6. doi: 10.1212/wnl.47.2.462. Neurology. 1996. PMID: 8757021

8

Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography trace for measurement of acetylcholinesterase activity in human brain.

Koeppe RA, Frey KA, Snyder SE, Meyer P, Kilbourn MR, Kuhl DE. Koeppe RA, et al. Among authors: frey ka. J Cereb Blood Flow Metab. 1999 Oct;19(10):1150-63. doi: 10.1097/00004647-199910000-00012. J Cereb Blood Flow Metab. 1999. PMID: 10532640

9

Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex.

Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA. Kuhl DE, et al. Among authors: frey ka. Ann Neurol. 2000 Sep;48(3):391-5. Ann Neurol. 2000. PMID: 10976649 Free article.

10

Radiotracers and analytical approaches in positron and single-photon emission tomography.

Frey KA. Frey KA. Adv Neurol. 2000;83:61-7. Adv Neurol. 2000. PMID: 10999189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters